TITLE

Quinolone-Resistant

AUTHOR(S)
Smith, Kirk E.; Besser, John M.; Hedberg, Craig W.; Leano, Fe T.; Bender, Jeffrey B.; Wicklund, Julie H.; Johnson, Brian P.; Moore, Kristine A.; Osterholm, Michael T.
PUB. DATE
May 1999
SOURCE
New England Journal of Medicine;05/20/99, Vol. 340 Issue 20, p1525
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Increasing resistance to quinolones among campylobacter isolates from humans has been reported in Europe and Asia, but not in the United States. We evaluated resistance to quinolones among campylobacter isolates from Minnesota residents during the period from 1992 through 1998. Methods: All 4953 campylobacter isolates from humans received by the Minnesota Department of Health were tested for resistance to nalidixic acid. Resistant isolates and selected sensitive isolates were tested for resistance to ciprofloxacin. We conducted a case-comparison study of patients with ciprofloxacin-resistant Campylobacter jejuni isolated during 1996 and 1997. Domestic chicken was evaluated as a potential source of quinolone-resistant campylobacter. Results: The proportion of quinolone-resistant C. jejuni isolates from humans increased from 1.3 percent in 1992 to 10.2 percent in 1998 (P<0.001). During 1996 and 1997, infection with quinolone-resistant C. jejuni was associated with foreign travel and with the use of a quinolone before the collection of stool specimens. However, quinolone use could account for no more than 15 percent of the cases from 1996 through 1998. The number of quinolone-resistant infections that were acquired domestically also increased during the period from 1996 through 1998. Ciprofloxacin-resistant C. jejuni was isolated from 14 percent of 91 domestic chicken products obtained from retail markets in 1997. Molecular subtyping showed an association between resistant C. jejuni strains from chicken products and domestically acquired infections in Minnesota residents. Conclusions: The increase in quinolone-resistant C. jejuni infections in Minnesota is largely due to infections acquired during foreign travel. However, the number of quinolone-resistant infections acquired domestically has also increased, largely because of the acquisition of resistant strains from poultry. The use of fluoroquinolones in poultry, which began in the United States in 1995, has created a reservoir of resistant C. jejuni. (N Engl J Med 1999;340:1525-32.)
ACCESSION #
9605097754

 

Related Articles

  • Campylobacter upsaliensis: Another Pathogen for Consideration in the United States. Labarca, Jaime A.; Sturgeon, Joan; Bernstein, Lee; Salem, Nancy; Harvey, Sydney M.; Lehnkering, Eleanor; Reporter, Roshan; Mascola, Laurene // Clinical Infectious Diseases;6/1/2002, Vol. 34 Issue 11, pe59 

    Presents a study which evaluated quinolone resistance in a sample of Campylobacter isolates recovered from patients with campylobacteriosis in Los Angeles County, California in 1998. Number of cases of campylobacteriosis for which no isolates were available; Classification of the isolates;...

  • Source Attribution of Human Campylobacter Isolates by MLST and Fla-Typing and Association of Genotypes with Quinolone Resistance. Kittl, Sonja; Heckel, Gerald; Korczak, Bożena M.; Kuhnert, Peter // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Campylobacteriosis is the most frequent zoonosis in developed countries and various domestic animals can function as reservoir for the main pathogens Campylobacter jejuni and Campylobacter coli. In the present study we compared population structures of 730 C. jejuni and C. coli from human cases,...

  • Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia. Unicomb, Leanne; Ferguson, John; Riley, Thomas V.; Collignon, Peter // Emerging Infectious Diseases;Nov2003, Vol. 9 Issue 11, p1482 

    Fluoroquinolone resistance was detected in 12 of 370 Australian human Campylobacter isolates; 10 of these were travel-associated, and for 2 isolates travel status was unknown. No resistance was found in isolates known to be locally acquired. In Australia, fluoroquinolones have not been licensed...

  • Prevalence of antibiotic resistance in Campylobacter isolates from commercial poultry suppliers in KwaZulu-Natal, South Africa. L. A. Bester; S. Y. Essack // Journal of Antimicrobial Chemotherapy (JAC);Dec2008, Vol. 62 Issue 6, p1298 

    : Objectives Campylobacter jejuni isolated from broiler and layer chickens from registered abattoirs in KwaZulu-Natal, South Africa, were tested for their susceptibility to eight antibiotics. : Methods Using agar dilution, susceptibility to eight antibiotics was determined for C. jejuni...

  • Resistance complicates oral antibiotic treatments. Jesitus, John // Dermatology Times;Sep2004, Vol. 25 Issue 9, p33 

    Reports on the issue of drug resistance among oral antibiotic treatments. Use of oral quinolones for certain infections like Pseudomonas; Administration of linezolid orally and intravenously; Effectiveness of linezolid for treatment of infections where there may be resistance to other...

  • Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo. Gulibahaer Bakeli; Kenya Sato; Wakako Kumita; Toshio Chida; Noboru Okamura // Journal of Infection & Chemotherapy;Oct2008, Vol. 14 Issue 5, p342 

    Abstract��We determined the minimum inhibitory concentrations of six types of antimicrobial agents for 523 strains of Campylobacter jejuni that were isolated from diarrheal patients in a general hospital in Tokyo during the period between 2003 and 2005. It was revealed that 20.2%,...

  • Emergence of Cotrimoxazole- and Quinolone-Resistant Campylobacter Infections in Bone Marrow Transplant Recipients. Lau, S. K. P.; Woo, P. C. Y.; Leung, K. W.; Yuen, K. Y. // European Journal of Clinical Microbiology & Infectious Diseases;Feb2002, Vol. 21 Issue 2, p127 

    Clinical and microbiological data were collected prospectively from 704 patients who underwent bone marrow transplantation (BMT) during an 11-year period (1991–2001), and the first two cases of Campylobacter infection occurring in BMT recipients in the pre-engraftment period were...

  • Antimicrobial Resistance among Campylobacter Strains, United States, 1997-2001. Gupta, Amita; Nelson, Jennifer M.; Barrett, Timothy J.; Tauxe, Robert V.; Rossiter, Shannon P.; Friedman, Cindy R.; Joyce, Kevin W.; Angulo, Frederick J.; Smith, Kirk E.; Jones, Timothy F.; Hawkins, Marguerite A.; Shiferaw, Beletshachew; Beebe, James L.; Vugia, Duc J.; Rabatsky-Ehr, Terry; Benson, James A.; Root, Timothy P. // Emerging Infectious Diseases;Jun2004, Vol. 10 Issue 6, p1102 

    We summarize antimicrobial resistance surveillance data in human and chicken isolates of Campylobacter. Isolates were from a sentinel county study from 1989 through 1990 and from nine state health departments participating in National Antimicrobial Resistance Monitoring System for enteric...

  • Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates. Engberg, Jorgen; Gerner-Smidt, Peter; Aarestrup, Frank M.; Taylor, Diane E.; Nachamkin, Irving // Emerging Infectious Diseases;Jan/Feb2001, Vol. 7 Issue 1, p24 

    The incidence of human Campylobacterjejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics